Cargando…
Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post‐COVID‐19 condition
BACKGROUND: The post‐COVID‐19 condition (PCC) consists of a wide array of symptoms including fatigue and impaired daily living. People seek a wide variety of approaches to help them recover. A new belief, arising from a few laboratory studies, is that 'microclots' cause the symptoms of PCC...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Ltd
2023
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368521/ https://www.ncbi.nlm.nih.gov/pubmed/37491597 http://dx.doi.org/10.1002/14651858.CD015775 |